![](https://webarchive.library.unt.edu/eot2008/20090118123309im_/http://www.fda.gov/cder/templates/graphics/dot_clear.gif) |
Prescription and Over-the-Counter Drug Product List
28th Edition
Cumulative Supplement Number 3: March 2008
NOTE: The format for the Monthly Additions/Deletions Drug
Product List changed as of the July Cumulative Supplement (CS) of the 21st
Edition to mirror the CS. Refer to the CS Preface section 1.6
Cumulative Supplement Legend. ![PDF](https://webarchive.library.unt.edu/eot2008/20090118123309im_/http://www.fda.gov/cder/graphics/pdf.gif)
ALOSETRON HYDROCHLORIDE
TABLET; ORAL
LOTRONEX
>D> GLAXOSMITHKLINE EQ 0.5MG BASE N21107 002 Dec 23, 2003 Mar CAHN
>D> + EQ 1MG BASE N21107 001 Feb 09, 2000 Mar CAHN
>A> PROMETHEUS LABS EQ 0.5MG BASE N21107 002 Dec 23, 2003 Mar CAHN
>A> + EQ 1MG BASE N21107 001 Feb 09, 2000 Mar CAHN
AMIFOSTINE
INJECTABLE; INJECTION
>A> AMIFOSTINE
>A> AP SUN PHARM INDS 500MG/VIAL N77126 001 Mar 14, 2008 Mar NEWA
ETHYOL
>D> + MEDIMMUNE 500MG/VIAL N20221 001 Dec 08, 1995 Mar CFTG
>A> AP + 500MG/VIAL N20221 001 Dec 08, 1995 Mar CFTG
>A> BENDAMUSTINE HYDROCHLORIDE
>A> POWDER; IV (INFUSION)
>A> TREANDA
>A> + CEPHALON 100MG/VIAL N22249 001 Mar 20, 2008 Mar NEWA
BENZONATATE
CAPSULE; ORAL
BENZONATATE
>A> AA SUN PHARM INDS INC 100MG N40587 001 Mar 19, 2008 Mar NEWA
>A> AA 200MG N40587 002 Mar 19, 2008 Mar NEWA
BETHANECHOL CHLORIDE
TABLET; ORAL
BETHANECHOL CHLORIDE
>A> AA LANNETT 5MG N40703 001 Mar 27, 2008 Mar NEWA
>A> AA 10MG N40704 001 Mar 27, 2008 Mar NEWA
>A> AA 25MG N40678 003 Mar 27, 2008 Mar NEWA
>A> AA 50MG N40677 001 Mar 27, 2008 Mar NEWA
BUPROPION HYDROCHLORIDE
TABLET, EXTENDED RELEASE; ORAL
BUPROPION HYDROCHLORIDE
>D> AB1 ACTAVIS 150MG N77475 001 Mar 12, 2008 Mar CTEC
>A> AB2 150MG N77475 001 Mar 12, 2008 Mar CTEC
>A> AB1 150MG N77455 002 Mar 12, 2008 Mar NEWA
CEFAZOLIN SODIUM
INJECTABLE; INJECTION
KEFZOL
>D> @ ACS DOBFAR EQ 500MG BASE/VIAL N61773 002 Mar CMFD
>A> AP EQ 500MG BASE/VIAL N61773 002 Mar CMFD
>D> @ EQ 1GM BASE/VIAL N61773 003 Mar CMFD
>A> AP EQ 1GM BASE/VIAL N61773 003 Mar CMFD
>D> @ EQ 10GM BASE/VIAL N61773 004 Mar CMFD
>A> AP EQ 10GM BASE/VIAL N61773 004 Mar CMFD
CEFEPIME HYDROCHLORIDE
INJECTABLE; INJECTION
CEFEPIME HYDROCHLORIDE
>A> AP ACS DOBFAR 1GM/VIAL N65441 001 Mar 20, 2008 Mar NEWA
>A> AP 2GM/VIAL N65441 002 Mar 20, 2008 Mar NEWA
CEFPROZIL
TABLET; ORAL
CEFPROZIL
>A> AB APOTEX INC 250MG N65327 001 Mar 26, 2008 Mar NEWA
>A> AB 500MG N65327 002 Mar 26, 2008 Mar NEWA
CIPROFLOXACIN
INJECTABLE; INJECTION
CIPRO IN DEXTROSE 5% IN PLASTIC CONTAINER
>D> + BAYER PHARMS 200MG/100ML N19857 001 Dec 26, 1990 Mar CFTG
>A> AP + 200MG/100ML N19857 001 Dec 26, 1990 Mar CFTG
>A> AP + 400MG/200ML N19857 002 Dec 26, 1990 Mar CFTG
>A> CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER
>A> AP ACS DOBFAR INFO SA 200MG/100ML N78252 001 Mar 18, 2008 Mar NEWA
>A> AP 400MG/200ML N78252 002 Mar 18, 2008 Mar NEWA
>A> AP BAXTER HLTHCARE 200MG/100ML N77888 001 Mar 18, 2008 Mar NEWA
>A> AP 400MG/200ML N77888 002 Mar 18, 2008 Mar NEWA
>A> AP BEDFORD 200MG/100ML N78114 001 Mar 18, 2008 Mar NEWA
>A> AP 400MG/200ML N78114 002 Mar 18, 2008 Mar NEWA
>A> AP CLARIS 200MG/100ML N78024 001 Mar 18, 2008 Mar NEWA
>A> AP 400MG/200ML N78024 002 Mar 18, 2008 Mar NEWA
>A> AP HOSPIRA 200MG/100ML N77753 001 Mar 18, 2008 Mar NEWA
>A> AP 400MG/200ML N77753 002 Mar 18, 2008 Mar NEWA
>A> AP TEVA PARENTERAL 200MG/100ML N77138 001 Mar 18, 2008 Mar NEWA
>A> AP 400MG/200ML N77138 002 Mar 18, 2008 Mar NEWA
CITALOPRAM HYDROBROMIDE
TABLET; ORAL
CITALOPRAM HYDROBROMIDE
>D> AB KALI LABS EQ 10MG BASE N77042 001 Nov 05, 2004 Mar CAHN
>D> AB EQ 20MG BASE N77042 002 Nov 05, 2004 Mar CAHN
>D> AB EQ 40MG BASE N77042 003 Nov 05, 2004 Mar CAHN
>A> AB MATRIX LABS INC EQ 10MG BASE N77042 001 Nov 05, 2004 Mar CAHN
>A> AB EQ 20MG BASE N77042 002 Nov 05, 2004 Mar CAHN
>A> AB EQ 40MG BASE N77042 003 Nov 05, 2004 Mar CAHN
>A> AB NATCO PHARMA LTD EQ 20MG BASE N77141 002 Apr 10, 2008 Mar NEWA
>A> AB EQ 40MG BASE N77141 001 Apr 10, 2008 Mar NEWA
CLOZAPINE
TABLET; ORAL
CLOZAPINE
>D> AB TEVA 25MG N75162 001 Apr 26, 2005 Mar DISC
>A> @ 25MG N75162 001 Apr 26, 2005 Mar DISC
>D> AB 100MG N75162 002 Apr 26, 2005 Mar DISC
>A> @ 100MG N75162 002 Apr 26, 2005 Mar DISC
COLISTIMETHATE
INJECTABLE; INJECTION
COLISTIMETHATE
>A> AP APP PHARMS EQ 150MG BASE/VIAL N65364 001 Apr 17, 2008 Mar NEWA
CYCLOBENZAPRINE HYDROCHLORIDE
TABLET; ORAL
CYCLOBENZAPRINE HYDROCHLORIDE
>A> AB AMNEAL PHARM 10MG N78218 001 Apr 18, 2008 Mar NEWA
DICLOFENAC SODIUM
SOLUTION/DROPS; OPHTHALMIC
DICLOFENAC SODIUM
>A> AT AKORN 0.1% N77845 001 Apr 17, 2008 Mar NEWA
ESTRADIOL; NORETHINDRONE ACETATE
TABLET; ORAL
ACTIVELLA
>D> + NOVO NORDISK INC 1MG;0.5MG N20907 001 Nov 18, 1998 Mar CFTG
>A> AB + 1MG;0.5MG N20907 001 Nov 18, 1998 Mar CFTG
>A> ESTRADIOL AND NORETHIDRONE ACETATE
>A> AB BRECKENRIDGE 1MG;0.5MG N78324 001 Apr 17, 2008 Mar NEWA
FELODIPINE
TABLET, EXTENDED RELEASE; ORAL
FELODIPINE
>A> AB MYLAN 2.5MG N78855 001 Apr 17, 2008 Mar NEWA
>A> AB 5MG N78855 002 Apr 17, 2008 Mar NEWA
>A> AB 10MG N78855 003 Apr 17, 2008 Mar NEWA
FENOFIBRATE
TABLET; ORAL
FENOFIBRATE
>A> AB IMPAX LABS 54MG N76509 001 Mar 26, 2008 Mar NEWA
>A> AB 160MG N76509 002 Mar 26, 2008 Mar NEWA
FEXOFENADINE HYDROCHLORIDE
TABLET; ORAL
FEXOFENADINE HYDROCHLORIDE
>A> AB MYLAN 30MG N77081 002 Apr 11, 2008 Mar NEWA
>A> AB 60MG N77081 003 Apr 11, 2008 Mar NEWA
FLUOROURACIL
CREAM; TOPICAL
EFUDEX
>D> + VALEANT PHARM 5% N16831 003 Mar CFTG
>A> AB + 5% N16831 003 Mar CFTG
>A> FLUOROURACIL
>A> AB SPEAR PHARMS 5% N77524 001 Apr 11, 2008 Mar NEWA
FOSPHENYTOIN SODIUM
INJECTABLE; INJECTION
FOSPHENYTOIN SODIUM
>A> AP AKORN STRIDES EQ 50MG PNENYTOIN NA/ML N78476 001 Mar 18, 2008 Mar NEWA
>A> AP SUN PHARM INDS EQ 50MG PHENYTOIN NA/ML N78417 001 Mar 18, 2008 Mar NEWA
GABAPENTIN
CAPSULE; ORAL
GABAPENTIN
>D> AB MUTUAL PHARM 100MG N76537 001 Jun 30, 2005 Mar DISC
>A> @ 100MG N76537 001 Jun 30, 2005 Mar DISC
>D> AB 300MG N76537 002 Jun 30, 2005 Mar DISC
>A> @ 300MG N76537 002 Jun 30, 2005 Mar DISC
>D> AB 400MG N76537 003 Jun 30, 2005 Mar DISC
>A> @ 400MG N76537 003 Jun 30, 2005 Mar DISC
GLUTAMINE
FOR SOLUTION; ORAL
NUTRESTORE
>D> @ NUTRITIONAL 5GM/PACKET N21667 001 Jun 10, 2004 Mar CMFD
>A> + 5GM/PACKET N21667 001 Jun 10, 2004 Mar CMFD
GLYCOPYRROLATE
TABLET; ORAL
GLYCOPYRROLATE
>A> AA INDICUS PHARMA 1MG N40847 001 Mar 21, 2008 Mar NEWA
>A> AA 2MG N40847 002 Mar 21, 2008 Mar NEWA
GRISEOFULVIN, MICROCRYSTALLINE
TABLET; ORAL
>D> FULVICIN-U/F
>D> AB + SCHERING 250MG N60569 002 Mar DISC
>A> @ 250MG N60569 002 Mar DISC
>D> AB + 500MG N60569 001 Mar DISC
>A> @ 500MG N60569 001 Mar DISC
GRIFULVIN V
>D> AB ORTHONEUTROGENA 250MG N62279 002 Mar CRLD
>A> + 250MG N62279 002 Mar CRLD
>D> AB 500MG N62279 003 Mar CRLD
>A> + 500MG N62279 003 Mar CRLD
>D> HYDROXYZINE
>D> TABLET; ORAL
>D> HYDROXYZINE HYDROCHLORIDE
>D> AB INVAGEN PHARMS 10MG N40812 001 Mar 12, 2008 Mar CAIN
>D> AB 25MG N40812 002 Mar 12, 2008 Mar CAIN
>D> AB 50MG N40812 003 Mar 12, 2008 Mar CAIN
>A> HYDROXYZINE HYDROCHLORIDE
>A> TABLET; ORAL
>A> HYDROXYZINE HYDROCHLORIDE
>A> AB INVAGEN PHARMS 10MG N40812 001 Mar 12, 2008 Mar CAIN
>A> AB 25MG N40812 002 Mar 12, 2008 Mar CAIN
>A> AB 50MG N40812 003 Mar 12, 2008 Mar CAIN
>A> AB NORTHSTAR 10MG N40841 001 Mar 31, 2008 Mar NEWA
>A> AB 25MG N40842 001 Mar 31, 2008 Mar NEWA
>A> AB 50MG N40840 001 Mar 31, 2008 Mar NEWA
INDAPAMIDE
TABLET; ORAL
INDAPAMIDE
>D> AB MYLAN 2.5MG N74461 001 Mar 27, 1996 Mar CRLD
>A> AB + 2.5MG N74461 001 Mar 27, 1996 Mar CRLD
LOZOL
>D> AB SANOFI AVENTIS US 1.25MG N18538 002 Apr 29, 1993 Mar DISC
>A> @ 1.25MG N18538 002 Apr 29, 1993 Mar DISC
>D> AB + 2.5MG N18538 001 Jul 06, 1983 Mar DISC
>A> @ 2.5MG N18538 001 Jul 06, 1983 Mar DISC
ISONIAZID
TABLET; ORAL
ISONIAZID
>D> AA MUTUAL PHARM 300MG N83633 001 Mar DISC
>A> @ 300MG N83633 001 Mar DISC
ISOSORBIDE DINITRATE
TABLET, EXTENDED RELEASE; ORAL
ISOSORBIDE DINITRATE
>A> AB COREPHARMA 40MG N40723 001 Mar 17, 2008 Mar NEWA
>D> + INWOOD LABS 40MG N40009 001 Dec 30, 1998 Mar CTEC
>A> AB + 40MG N40009 001 Dec 30, 1998 Mar CTEC
LEVALBUTEROL HYDROCHLORIDE
SOLUTION; INHALATION
>A> LEVALBUTEROL HYDROCHLORIDE
>A> AN BREATH LTD EQ 0.0103% BASE N77756 003 Apr 09, 2008 Mar NEWA
>A> AN EQ 0.021% BASE N77756 001 Apr 09, 2008 Mar NEWA
>A> AN EQ 0.042% BASE N77756 002 Apr 09, 2008 Mar NEWA
XOPENEX
>D> + SEPRACOR EQ 0.0103% BASE N20837 003 Jan 30, 2002 Mar CFTG
>A> AN + EQ 0.0103% BASE N20837 003 Jan 30, 2002 Mar CFTG
>D> + EQ 0.021% BASE N20837 001 Mar 25, 1999 Mar CFTG
>A> AN + EQ 0.021% BASE N20837 001 Mar 25, 1999 Mar CFTG
>D> + EQ 0.042% BASE N20837 002 Mar 25, 1999 Mar CFTG
>A> AN + EQ 0.042% BASE N20837 002 Mar 25, 1999 Mar CFTG
>A> LEVOLEUCOVORIN CALCIUM
>A> POWDER; IV (INFUSION)
>A> LEVOLEUCOVORIN
>A> + SPECTRUM PHARMS EQ 50MG BASE/VIAL N20140 001 Mar 07, 2008 Mar NEWA
LITHIUM CARBONATE
CAPSULE; ORAL
LITHIUM CARBONATE
>D> + ROXANE 600MG N17812 003 Jan 28, 1987 Mar CTEC
>A> AB + 600MG N17812 003 Jan 28, 1987 Mar CTEC
>A> AB WEST WARD 600MG N78763 001 Apr 15, 2008 Mar NEWA
LOVASTATIN
TABLET; ORAL
LOVASTATIN
>A> AB LUPIN 10MG N78296 001 Mar 14, 2008 Mar NEWA
METFORMIN HYDROCHLORIDE
TABLET, EXTENDED RELEASE; ORAL
METFORMIN HYDROCHLORIDE
>A> AB NEUROSCI INC 500MG N78321 001 Apr 17, 2008 Mar NEWA
>A> AB 750MG N78321 002 Apr 17, 2008 Mar NEWA
METOCLOPRAMIDE HYDROCHLORIDE
TABLET, ORALLY DISINTEGRATING; ORAL
REGLAN ODT
>A> @ ALAVEN PHARM EQ 5MG BASE N21793 001 Jun 10, 2005 Mar CAHN
>A> @ EQ 10MG BASE N21793 002 Jun 10, 2005 Mar CAHN
>D> @ SCHWARZ PHARMA EQ 5MG BASE N21793 001 Jun 10, 2005 Mar CAHN
>D> @ EQ 10MG BASE N21793 002 Jun 10, 2005 Mar CAHN
TABLET; ORAL
REGLAN
>A> AB ALAVEN PHARM EQ 5MG BASE N17854 002 May 05, 1987 Mar CAHN
>A> AB + EQ 10MG BASE N17854 001 Mar CAHN
>D> AB SCHWARZ PHARMA EQ 5MG BASE N17854 002 May 05, 1987 Mar CAHN
>D> AB + EQ 10MG BASE N17854 001 Mar CAHN
METOPROLOL SUCCINATE
TABLET, EXTENDED RELEASE; ORAL
METOPROLOL SUCCINATE
>A> AB KV PHARM EQ 25MG TARTRATE N77779 001 Mar 20, 2008 Mar NEWA
>A> AB SANDOZ EQ 100MG TARTRATE N76969 003 Mar 20, 2008 Mar NEWA
>A> AB EQ 200MG TARTRATE N76969 004 Mar 20, 2008 Mar NEWA
METRONIDAZOLE
INJECTABLE; INJECTION
METRONIDAZOLE IN PLASTIC CONTAINER
>A> AP CLARIS 500MG/100ML N78084 001 Mar 31, 2008 Mar NEWA
MINOXIDIL
TABLET; ORAL
MINOXIDIL
>D> AB WATSON LABS 10MG N71345 001 Mar 03, 1987 Mar CRLD
>A> AB + 10MG N71345 001 Mar 03, 1987 Mar CRLD
MORPHINE SULFATE
>A> SOLUTION; ORAL
>A> MORPHINE SULFATE
>A> ROXANE 10MG/5ML N22195 001 Mar 17, 2008 Mar NEWA
>A> + 20MG/5ML N22195 002 Mar 17, 2008 Mar NEWA
>A> TABLET; ORAL
>A> MORPHINE SULFATE
>A> ROXANE 15MG N22207 001 Mar 17, 2008 Mar NEWA
>A> + 30MG N22207 002 Mar 17, 2008 Mar NEWA
OFLOXACIN
SOLUTION/DROPS; OPHTHALMIC
OFLOXACIN
>A> AT AKORN 0.3% N76407 001 Apr 15, 2008 Mar NEWA
SOLUTION/DROPS; OTIC
OFLOXACIN
>A> AT ALCON 0.3% N78222 001 Mar 17, 2008 Mar NEWA
>A> AT BAUSCH AND LOMB 0.3% N76128 001 Mar 17, 2008 Mar NEWA
>A> AT HI TECH PHARMA 0.3% N76616 001 Mar 17, 2008 Mar NEWA
>A> OMEPRAZOLE MAGNESIUM
>A> FOR SUSPENSION, DELAYED RELEASE; ORAL
>A> PRILOSEC
>A> ASTRAZENECA EQ 2.5MG BASE/PACKET N22056 001 Mar 20, 2008 Mar NEWA
>A> + EQ 10MG BASE/PACKET N22056 002 Mar 20, 2008 Mar NEWA
ONDANSETRON HYDROCHLORIDE
INJECTABLE; INJECTION
ONDANSETRON HYDROCHLORIDE AND DEXTROSE IN PLASTIC CONTAINER
>A> AP CLARIS EQ 0.64MG BASE/ML N78308 001 Mar 17, 2008 Mar NEWA
ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE
>A> AP TARO PHARMS EQ 2MG BASE/ML N78014 001 Mar 21, 2008 Mar NEWA
OXCARBAZEPINE
TABLET; ORAL
OXCARBAZEPINE
>A> AB APOTEX INC 150MG N77747 001 Apr 09, 2008 Mar NEWA
>A> AB 300MG N77747 002 Apr 09, 2008 Mar NEWA
>A> AB 600MG N77747 003 Apr 09, 2008 Mar NEWA
>D> OXYTETRACYCLINE HYDROCHLORIDE
>D> CAPSULE; ORAL
>D> TERRAMYCIN
>D> + PFIZER EQ 250MG BASE N50286 002 Mar DISC
>A> @ EQ 250MG BASE N50286 002 Mar DISC
OXYTOCIN
>A> INJECTABLE; INJECTION
>A> OXYTOCIN
>A> AP + BAXTER HLTHCARE 100USP UNITS/10ML (10USP UNITS/ML) N18243 002 Jan 10, 2007 Mar CDFR
>D> INJECTABLE; INTRAMUSCULAR, IV (INFUSION)
>D> OXYTOCIN
>D> AP + BAXTER HLTHCARE 100USP UNITS/10ML (10USP UNITS/ML) N18243 002 Jan 10, 2007 Mar CDFR
PAROXETINE HYDROCHLORIDE
TABLET; ORAL
PAROXETINE HYDROCHLORIDE
>A> AB MYLAN EQ 10MG BASE N78902 001 Mar 13, 2008 Mar NEWA
>A> AB EQ 20MG BASE N78902 002 Mar 13, 2008 Mar NEWA
>A> AB EQ 30MG BASE N78902 003 Mar 13, 2008 Mar NEWA
>A> AB EQ 40MG BASE N78902 004 Mar 13, 2008 Mar NEWA
PHENDIMETRAZINE TARTRATE
TABLET; ORAL
PHENDIMETRAZINE TARTRATE
>A> AA ACTAVIS TOTOWA 35MG N40762 001 Jan 28, 2008 Mar CAHN
>D> AA AMIDE PHARM 35MG N40762 001 Jan 28, 2008 Mar CAHN
PHENTERMINE HYDROCHLORIDE
CAPSULE; ORAL
PHENTERMINE HYDROCHLORIDE
>A> AA KVK TECH 15MG N40886 002 Mar 31, 2008 Mar NEWA
>A> AA 30MG N40886 001 Mar 31, 2008 Mar NEWA
>A> AA 30MG N40875 001 Mar 21, 2008 Mar NEWA
TABLET; ORAL
PHENTERMINE HYDROCHLORIDE
>A> AA KVK TECH 37.5MG N40876 001 Mar 31, 2008 Mar NEWA
PHENYTOIN SODIUM
INJECTABLE; INJECTION
PHENYTOIN SODIUM
>A> AP + BAXTER 50MG/ML N84307 001 Mar CAHN
>D> AP + ELKINS SINN 50MG/ML N84307 001 Mar CAHN
QUETIAPINE FUMARATE
TABLET, EXTENDED RELEASE; ORAL
SEROQUEL XR
>D> ASTRAZENECA EQ 200MG BASE N22047 002 May 17, 2007 Mar CRLD
>A> + EQ 200MG BASE N22047 002 May 17, 2007 Mar CRLD
>D> + EQ 400MG BASE N22047 004 May 17, 2007 Mar CRLD
>A> EQ 400MG BASE N22047 004 May 17, 2007 Mar CRLD
RIFAMPIN
CAPSULE; ORAL
RIFAMPIN
>A> AB LANNETT 150MG N65390 001 Mar 28, 2008 Mar NEWA
>A> AB 300MG N65390 002 Mar 28, 2008 Mar NEWA
SOTALOL HYDROCHLORIDE
TABLET; ORAL
SOTALOL HYDROCHLORIDE
>D> AB2 MUTUAL PHARM 80MG N76576 001 Apr 08, 2004 Mar DISC
>A> @ 80MG N76576 001 Apr 08, 2004 Mar DISC
>D> AB2 120MG N76576 002 Apr 08, 2004 Mar DISC
>A> @ 120MG N76576 002 Apr 08, 2004 Mar DISC
>D> AB2 160MG N76576 003 Apr 08, 2004 Mar DISC
>A> @ 160MG N76576 003 Apr 08, 2004 Mar DISC
SPIRONOLACTONE
TABLET; ORAL
SPIRONOLACTONE
>D> AB MUTUAL PHARM 25MG N87265 001 Mar DISC
>A> @ 25MG N87265 001 Mar DISC
SULFAMETHOXAZOLE; TRIMETHOPRIM
INJECTABLE; INJECTION
SULFAMETHOXAZOLE AND TRIMETHOPRIM
>D> AP BAXTER HLTHCARE 80MG/ML;16MG/ML N70628 001 Dec 29, 1987 Mar DISC
>A> @ 80MG/ML;16MG/ML N70628 001 Dec 29, 1987 Mar DISC
>D> AP HOSPIRA 80MG/ML;16MG/ML N73199 001 Sep 11, 1992 Mar DISC
>A> @ 80MG/ML;16MG/ML N73199 001 Sep 11, 1992 Mar DISC
>D> AP TEVA PARENTERAL 80MG/ML;16MG/ML N73303 001 Oct 31, 1991 Mar CRLD
>A> + 80MG/ML;16MG/ML N73303 001 Oct 31, 1991 Mar CRLD
SULFASALAZINE
TABLET; ORAL
SULFASALAZINE
>D> AB MUTUAL PHARM 500MG N89590 001 Oct 19, 1987 Mar DISC
>A> @ 500MG N89590 001 Oct 19, 1987 Mar DISC
TECHNETIUM TC-99M MEDRONATE KIT
INJECTABLE; INJECTION
DRAXIMAGE MDP-25
>D> + DRAXIMAGE N/A N18035 002 Feb 27, 2004 Mar CTEC
>A> AP + N/A N18035 002 Feb 27, 2004 Mar CTEC
TIROFIBAN HYDROCHLORIDE
INJECTABLE; INJECTION
AGGRASTAT
>D> + MEDICURE EQ 12.5MG BASE/50ML (EQ 0.25MG N20912 001 May 14, 1998 Mar DISC
>A> @ EQ 12.5MG BASE/50ML (EQ 0.25MG N20912 001 May 14, 1998 Mar DISC
TOBRAMYCIN SULFATE
INJECTABLE; INJECTION
>D> TOBRAMYCIN
>D> AP ABRAXIS PHARM EQ 10MG BASE/ML N65122 001 Nov 29, 2002 Mar CTNA
>D> AP + EQ 40MG BASE/ML N65122 002 Nov 29, 2002 Mar CTNA
>D> AP APP PHARMS EQ 1.2GM BASE/VIAL N50789 001 Jul 13, 2004 Mar CTNA
>D> AP + X GEN PHARMS EQ 1.2GM BASE/VIAL N65013 001 Aug 17, 2001 Mar CTNA
>D> TOBRAMYCIN (PHARMACY BULK)
>D> AP ABRAXIS PHARM EQ 40MG BASE/ML N65120 001 Nov 29, 2002 Mar CTNA
>A> TOBRAMYCIN SULFATE
>A> AP ABRAXIS PHARM EQ 10MG BASE/ML N65122 001 Nov 29, 2002 Mar CTNA
>A> AP + EQ 40MG BASE/ML N65122 002 Nov 29, 2002 Mar CTNA
>A> AP APP PHARMS EQ 1.2GM BASE/VIAL N50789 001 Jul 13, 2004 Mar CTNA
>A> AP + X GEN PHARMS EQ 1.2GM BASE/VIAL N65013 001 Aug 17, 2001 Mar CTNA
>A> TOBRAMYCIN SULFATE (PHARMACY BULK)
>A> AP ABRAXIS PHARM EQ 40MG BASE/ML N65120 001 Nov 29, 2002 Mar CTNA
>A> AVOBENZONE; ECAMSULE; OCTOCRYLENE; TITANIUM DIOXIDE
>A> CREAM; TOPICAL
>A> ANTHELIOS 40
>A> + LOREAL USA 2%;3%;10%;5% N22009 001 Mar 31, 2008 Mar NEWA
CETIRIZINE HYDROCHLORIDE
SYRUP; ORAL
>A> CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY
>A> PERRIGO R AND D 5MG/ML N90254 002 Apr 09, 2008 Mar NEWA
>A> CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF
>A> PERRIGO R AND D 5MG/ML N90254 001 Apr 09, 2008 Mar NEWA
CHILDREN'S ZYRTEC ALLERGY
>D> + MCNEIL CONSUMER 1MG/ML N22155 002 Nov 16, 2007 Mar CPOT
>A> + 5MG/5ML N22155 002 Nov 16, 2007 Mar CPOT
CHILDREN'S ZYRTEC HIVES RELIEF
>D> + MCNEIL CONSUMER 1MG/ML N22155 001 Nov 16, 2007 Mar CPOT
>A> + 5MG/5ML N22155 001 Nov 16, 2007 Mar CPOT
MINOXIDIL
SOLUTION; TOPICAL
MINOXIDIL (FOR WOMEN)
>A> HI TECH PHARMA 2% N74731 002 May 11, 2005 Mar NEWA
Back
to Top
Back to Additions/Deletions Index
Date created: April 18, 2008 |
![](https://webarchive.library.unt.edu/eot2008/20090118123309im_/http://www.fda.gov/cder/templates/graphics/dot_clear.gif) |